6840
F. Bustos et al. / Tetrahedron 58 (2002) 6837–6842
197 (17), 196 (base), 194 (2), 129 (2), 92 (5), 91 (59);
HRMS calcd for C20H23NO2 309.1729, found 309.1716.
flash chromatography (silica gel saturated with Et3N, 99:1
hexanes/Et3N) to yield 4c (75%, 55:45 dr). Data for the
diastereomeric mixture: 1H NMR d 0.93 (t, J¼6.9 Hz, 3H),
1.12–1.85 (m, 9H), 2.14–2.52 (m, 5H), 2.59–2.63 and
3.03–3.16 (2m, 2H), 4.00–4.13 (m, 3H), 7.19–7.31 (m,
5H); 13C NMR d 14.1, 14.4, 19.2, 19.3, 31.7 (C-4), 32.1
(C-4), 36.1, 36.4, 36.8, 37.5, 39.2, 40.7, 57.7, 58.4, 59.0,
59.9, 60.0, 60.2, 63.3 (C-2), 64.2 (C-2), 126.5, 126.6, 127.9,
128.0, 128.4, 128.7, 139.3, 139.7, 172.5 (CvO), 172.9
(CvO); IR (neat)n 1740 (CvO) cm21; LRMS (EI) m/z 289
(M, 22), 288 (base), 258 (2), 246 (4), 162 (7), 91 (29);
HRMS calcd for C18H27NO2 289.2042, found 289.1989.
4.2.2. 1-Benzyl-4-(ethoxycarbonylmethyl)-2-phenylpyr-
rolidine (4a). Representative procedure for formation
of adducts 2 and SmI2-promoted cyclization. A mixture
of 1a (1.17 g, 3.79 mmol), N-(hydroxymethyl)benzotriazole
˚
(576 mg, 3.79 mmol) and molecular sieves (4 A, 1.90 g) in
benzene (6 mL) was stirred at rt for 12 h. The resulting
mixture was filtered over Celite and evaporated to dryness
to yield the crude adduct 2a (1.73 g). The resulting residue
and t-BuOH (0.72 mL, 7.6 mmol) were dissolved in THF
(91 mL) and added dropwise to a solution of SmI2 (ca.
0.1 M in THF, 114 mL, 11.4 mmol) at 2788C. The mixture
was stirred at 2788C for an additional 30 min and allowed
to warm to room temperature. After further stirring for 2 h
the reaction mixture was quenched with a mixture of sat.
K2CO3 (100 mL) and water (100 mL). After separation, the
aqueous layer was extracted with EtOAc (3£200 mL), the
combined organic extracts were washed with a mixture of
water (100 mL) and brine (100 mL), dried (Na2SO4) and
evaporated to give a crude product that was purified by flash
chromatography (silica gel saturated with Et3N, 99:1
hexanes/Et3N) to yield 4a (968 mg, 79%, 64:36 dr) as an
4.2.5. Ethyl (Z )-4-[N-(tert-butoxycarbonyl)piperidin-2-
yl]prop-2-enoate (10Z ) and ethyl (E )-4-[N-(tert-butoxy-
carbonyl)piperidin-2-yl]prop-2-enoate (10E ). To a sol-
ution of 922 (6.81 g, 30.0 mmol) in CH2Cl2 (120 mL) at 08C
was added (ethoxycarbonylmethylene)triphenylphosphor-
ane (12.1 g, 33.0 mmol). The mixture was allowed to warm
to rt and further stirred for 3.5 h. The solvent was removed
in vacuo and the crude product was purified by flash
chromatography (86:14 hexanes/EtOAc) to yield in order of
elution 10Z (0.519 g, 6%) and 10E (7.68 g, 86%) as oils.
Data for 10Z: 1H NMR d 1.23 (t, J¼7.1 Hz, 3H, CH2CH3),
1.27–1.64 (m, 15H), 1.38 (s, t-Bu, included in m at 1.27–
1.64), 2.71–2.84 (m, 2H), 3.04–3.18 (m, 1H), 3.87–3.92
(br s, 1H), 4.11 (q, J¼7.1 Hz, 2H, CO2CH2), 4.28–4.42 (br
s, 1H), 5.75 (dt, J¼11.5, 1.6 Hz, 1H, H-30), 6.16 (dt, J¼11.5,
7.5 Hz, 1H, H-20); 13C NMR d 14.1, 18.9, 25.4, 28.3, 28.05,
29.4, 38.8 (br, C-6), 49.9 (br, C-2), 59.7, 79.1, 120.8 (C-3 ),
147.0 (C-20), 154.9 (NCO), 166.3 (CvO); IR (neat) n 1725
(CvO), 1695 (CvO), 1.650 (CvC) cm21; LRMS (EI) m/z
224 (29), 198 (13), 184 (75), 152 (40), 129 (39), 128 (base),
114 (16), 84 (18); HRMS calcd for C16H27NO4 297.1940,
found 297.1926. Data for 10E: 1H NMR d 1.25 (t,
J¼7.1 Hz, 3H, CH2CH3), 1.32–1.67 (m, 15H), 1.42 (s,
t-Bu, included in m at 1.32–1.67), 2.24–2.35 (m, 1H),
2.51–2.78 (m, 2H), 3.96–4.01 (m, 1H), 4.15 (q, J¼7.1 Hz,
2H, CO2CH2), 4.36 (br s W1/2¼18.6 Hz, 1H), 5.81 (dt,
J¼15.5, 1.4 Hz, 1H, H-30), 6.86 (dt, J¼15.5, 7.7 Hz, 1H,
H-20); 13C NMR d 14.2, 18.8, 25.3, 28.3,0 33.0, 38.7 (br,
C-6), 49.5 (br, C-2), 60.2, 79.4, 123.1 (C-3 ), 145.6 (C-20),
154.8 (NCO), 166.2 (CvO); IR (neat) n 1725 (CvO), 1690
(CvO), 1655 (CvC) cm21; LRMS (EI) m/z 224 (26), 198
(11), 184 (43), 152 (28), 129 (30), 128 (86), 114 (21), 84
(base); HRMS calcd for C16H27NO4, 297.1940, found
297.1929.
1
oil. Data for the diastereomeric mixture: H NMR d 1.22
and 1.23 (2t, J¼7.1 Hz, 3H), 1.39–1.50 and 1.85–2.10 (2m,
2H), 2.37–2.77 (m, 4H), 2.84 (dd, J¼9.3, 2.3 Hz) and 3.31
(dd, J¼9.1, 7.0 Hz) (total 1H), 3.05 (d, J¼13.4 Hz, 1H,
PhCH ), 3.44–3.52 (m, 1H), 3.85 (d, J¼13.5 Hz, 1H,
PhCH ), 4.09 and 4.10 (2q, J¼7.1 Hz, 2H, OCH2), 7.19–
7.51 (m, 10H, Ar); 13C NMR d 14.1, 32.2 (C-4), 32.4 (C-4),
39.5, 41.0, 41.3, 42.3, 57.5, 57.8, 58.3, 59.6, 60.1, 60.2, 68.4
(C-2), 69.6 (C-2), 126.6, 126.7, 127.0, 128.4, 128.4, 128.5,
139.2, 139.5, 143.1, 143.5, 172.5 (CvO), 172.9 (CvO); IR
(neat) n 1735 (CvO) cm21; LRMS (EI) m/z 323 (M, 39),
322 (28), 278 (23), 246 (85), 232 (83), 118 (20), 91 (base);
HRMS calcd for C21H25NO2 323.1885, found 323.1879.
4.2.3. 1-Benzyl-4-(ethoxycarbonylmethyl)-2-(pyridin-3-
yl)pyrrolidine (4b). Prepared from 1b21 using the pro-
cedure described above for 4a. The crude product was
purified by flash chromatography (silica gel saturated with
Et3N, 90:8:2 hexanes/EtOAc/Et3N) to yield 4b (66%, 65:35
dr). Data for the diastereomeric mixture: 1H NMR d 1.17–
1.25 (m, 3H, CH2CH3), 1.37–1.48 (m, 1H, isomer A),
1.97–2.01 (m, 1H), 2.36–2.86 (m, 5H), 3.10 (d, J¼13.2 Hz,
1H, PhCH ), 3.27–3.33 (m, 1H, isomer B), 3.48–3.53 (m,
1H), 3.77 (d, J¼13.2 Hz, 1H, PhCH ), 4.08 (m, 2H,
CH3CH2), 7.26 (br s, W1/2¼16.7 Hz, 6H), 7.81 (d,
J¼7.7 Hz, 1H, H-40), 8.49 (br s, W1/2¼8.3 Hz, 1H, H-20),
8.64 (br s, W1/2¼8.3 Hz, 1H, H-60); 13C NMR d 14.1, 32.3,
32.6, 39.1, 40.8, 41.2, 42.2, 57.5, 57.8, 58.3, 59.6, 60.2,
65.8, 67.0, 123.6, 126.8, 126.8, 128.1, 128.2, 128.4, 134.8,
134.9, 138.4, 138.7, 138.9, 139.0, 148.6, 148.7, 149.5, 172.3
(CvO), 172.6 (CvO); IR (neat) n 1740 (CvO),
1580 cm21; LRMS (EI) m/z 324 (M, 26), 323 (16), 279
(24), 246 (67), 236 (21), 233 (base), 219 (10), 119 (20), 91
(50); HRMS calcd for C20H24N2O2 324.1838, found
324.1835.
4.2.6. Ethyl (E )-4-(piperidin-2-yl)prop-2-enoate (1d).
Trifluoroacetic acid (2.60 mL) was added dropwise to a
solution of 10E (594 mg, 2.00 mmol) in CH2Cl2 (14.8 mL)
at 08C. The mixture was then stirred at rt for 3 h and
evaporated. The residue was dissolved in EtOAc (40 mL),
washed with sat. K2CO3 (40 mL), dried (Na2SO4) and
evaporated to dryness, to yield 1d (382 mg, 97%): 1H NMR
d 1.07–1.48 (m, 6H), 1.26 (t, 7.1H, CH2CH3, included in m
at 1.07–1.48), 1.56–1.79 (m, 3H), 2.04 (br s,
W1/2¼19.8 Hz, 1H, NH), 2.14–2.34 (m, 2H), 2.55–2.66
(m, 2H), 3.01–3.07 (m, 1H), 4.16 (q, J¼0 7.4 Hz, 2H,
CO2CH2), 5.86 (dt, J¼15.7, 1.4 Hz, 1H, H-3 ), 6.83–6.95
(m, 1H, H-20); 13C NMR d 14.2, 24.6, 26.0, 32.7, 40.1, 047.0,
55.6 (C-2), 60.3, 123.6 (C-30), 145.8 (C-20), 166.4 (C-4 ); IR
4.2.4. 1-Benzyl-4-(ethoxycarbonylmethyl)-2-propylpyr-
rolidine (4c). Prepared from 1c21 using the procedure
described above for 4a. The crude product was purified by
(neat) n 3400 (N–H), 1720 (CvO), 1655 (CvC) cm21
;